June 20, 2017 – Insomnia is one of the most common complaint people have about their health. In contrast to common belief and often assumed by the affected sufferers, however, insomnia seems not to be just all in the patients …

Genetic background of insomnia: At least partially Read more »

August 13, 2014 – The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra is an orexin receptor antagonist and is the first approved drug …

For those days or nights: FDA approves new type of sleep drug, Suvorexant [Belsomra] Read more »